A novel Bruton’s tyrosine kinase inhibitor CC-292 in...

Leukemia 2014 / 9 Vol. 28; Iss. 9

A novel Bruton’s tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity

Eda, H, Santo, L, Cirstea, D D, Yee, A J, Scullen, T A, Nemani, N, Mishima, Y, Waterman, P R, Arastu-Kapur, S, Evans, E, Singh, J, Kirk, C J, Westlin, W F, Raje, N S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2014.69
Date:
September, 2014
File:
PDF, 2.36 MB
english, 2014
Conversion to is in progress
Conversion to is failed